Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Opioid-Related Disorders × Olanzapine × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Anorexia 2 Weight Loss 1 Vomiting 1 Squamous Cell Carcinoma of Head and Neck 1 Opioid-Related Disorders 1 Neoplasms 1 Nausea 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Cachexia 1

Interventions

Ultrasonic Waves 1 Tirzepatide 1 Standard of Care 1 Olanzapine 1 Midazolam 1 Lidocaine 1 Educational Status 1 Buprenorphine, Naloxone Drug Combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06200181 2026-02-13

Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control Trial

M.D. Anderson Cancer Center

Phase 3 Recruiting

Opioid-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡